1. Early discharge as a mediator of greater ICU‐level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report. (29th July 2016) Authors: Getz, Kelly D.; Miller, Tamara P.; Seif, Alix E.; Li, Yimei; Huang, Yuan‐Shung; Alonzo, Todd; Gerbing, Robert; Sung, Lillian; Hall, Matthew; Bagatell, Rochelle; Gamis, Alan; Fisher, Brian T.; Aplenc, Richard Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Issue 1 (December 2016) Authors: Laszlo, George; Alonzo, Todd; Gudgeon, Chelsea; Harrington, Kimberly; Kentsis, Alex; Gerbing, Robert; Wang, Yi-Cheng; Ries, Rhonda; Raimondi, Susana; Hirsch, Betsy; Gamis, Alan; Meshinchi, Soheil; Walter, Roland Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗